Obermatt
See Similar Stocks →

CalciMedica

NAQ:CALC · US38942Q2021
PharmaceuticalsX-Small

360° View

no current rank
Price/Sales—
Price/Earnings—
Price/Book82
Dividend Yield1
Revenue Growth—
Profit Growth81
Capital Growth4
TSR 52w10
Leverage7
Liquidity25
Refinancing6
Combined—
Analyst Opinions47
Pro Holdings15
Opinion Changes50
Market Pulse47

Profile

CountryUSA
IndustryPharmaceuticals
SizeX-Small
TypePublic Company
ExchangeNASDAQCM
Employees17
Websitecalcimedica.com
ISINUS38942Q2021
Last UpdateApr 2, 2026
Index & Theme
GastroenterologyChronic DiseasesImmunologyNephrologyInflammationAllergyPulmonologyRespiratoryCentral Nervous SystemHealth CareInformation TechnologyLife Science

Description

CalciMedica, Inc. is a clinical-stage biopharmaceutical company. The company is focused on developing therapeutics that treat serious illnesses driven by inflammatory and immunologic processes and direct cellular damage. The company’s product candid…

Similar Stocks

The companies this stock is ranked against.

Compare CalciMedica with its peers
EyePoint
NMQ:EYPT
34
CountryUSA
IndustryPharmaceuticals
SizeSmall
Full Stock Analysis →
LB Pharmaceuticals
NMQ:LBRX
79
CountryUSA
IndustryPharmaceuticals
SizeSmall
Full Stock Analysis →
Ventyx Biosciences
NSQ:VTYX
51
CountryUSA
IndustryPharmaceuticals
SizeSmall
Full Stock Analysis →
Fulcrum Therapeutics
NMQ:FULC
24
CountryUSA
IndustryPharmaceuticals
SizeSmall
Full Stock Analysis →
Omeros
NMQ:OMER
29
CountryUSA
IndustryPharmaceuticals
SizeSmall
Full Stock Analysis →
Eledon Pharmaceuticals
NAQ:ELDN
16
CountryUSA
IndustryBiotechnology
SizeSmall
Full Stock Analysis →

Make Sense of the Ranks

Every rank runs 1–100 against true peers. Higher is always better.

360° View
1 · Watch OutGood· 100
Value
1 · ExpensiveGood Value· 100
Quality
1 · Weak FundamentalsHigh Quality· 100
Growth
1 · Tough TimesHigh Growth· 100
Safety
1 · High LeverageWell-Financed· 100
Sentiment
1 · SkepticismPositive· 100
Learn More →